drugset / Trial / NCT02620345

Fibroids in Women of Reproductive Age and Women Pregnancy

NCT02620345

Phase 4 Completed 22 enrolled Trieu, Nguyen Thi, M.D.
RandomizedParallel-groupOpen-labelTreatment

Summary

Dydrogesterone Multivitamin Nature treatment of fibroids in women of reproductive age and women pregnancy to lost the size fibroids.

Timeline

Start
2010-01
Primary completion
2015-10
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dydrogesterone Other / unclassified 15 mg
Background Calcium carbonate Other / unclassified 150 mg
Background Cholecalciferol Other / unclassified 400 iu
Background Dl-Alpha Tocopheryl Acetate Unknown 11 iu
Background Ferrous Sulfate Diagnostic / imaging agent 27 mg
Background Nicotinamide Other / unclassified 18 mg
Background Pyridoxine Unknown 2.6 mg
Background Riboflavin Other / unclassified 1.7 mg
Background Vitamin B12 Other / unclassified 4 ug
Background Vitamin C Other / unclassified 100 mg
Background Zinc Oxide Unknown 25 mg
Background beta-carotene Small molecule 4000 iu
Background folic acid Other / unclassified 400 ug
Background thiamine mononitrate Unknown 1.5 mg